Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, PK, and PD of a single dose of SAR438544 versus glucagon in Type 1 diabetes patients undergoing induced hypoglycemia; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)
• SAR438544

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: WITHDRAWN